Literature DB >> 6424976

Thyroid function in patients with homozygous beta-thalassaemia.

C Phenekos, A Karamerou, P Pipis, M Constantoulakis, J Lasaridis, S Detsi, K Politou.   

Abstract

Thyroid function was evaluated in 20 patients aged 8-30 years who were suffering from homozygous beta-thalassaemia. All patients have been receiving frequent blood transfusions and treated for the resulting transfusional iron overload with intramuscular injections of Desferrioxamine. Total thyroxine (T4), T3-uptake, total triiodothyronine (T3), and reverse triiodothyronine (rT3) were measured. In addition a standard TRH stimulation test was performed and blood samples were checked for the presence of thyroid antibodies. It was found that total T4 was significantly lower in the patients than in the controls. Total T3 and rT3 levels were similar in both patients and controls and all patients were negative for thyroid antibodies. T3 uptake in the patients was also statistically different from the controls resulting in significantly lower free thyroxine index (FT1). Basal TSH values were not different from the controls but the TSH increase following TRH stimulation was significantly higher in the patients suggesting, together with the low total T4 and FTI, a state of compensated hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424976     DOI: 10.1111/j.1365-2265.1984.tb03440.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Follow-up study of thyroid function in polytransfused thalassemic patients.

Authors:  M Maggiolini; G De Luca; M Bria; D Sisci; S Aquila; V Pezzi; M Lanzino; A Giorno; O Tamburrini; M Della Sala; E Corcioni; C Brancati; S Ando
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

2.  High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.

Authors:  S Mariotti; A Loviselli; S Murenu; F Sau; L Valentino; A Mandas; S Vacquer; E Martino; A Balestrieri; M E Lai
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

Review 3.  Growth and endocrine function in thalassemia major in childhood and adolescence.

Authors:  M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

4.  Impact of genotype on endocrinal complications in β-thalassemia patients.

Authors:  Ahmed Al-Akhras; Mohamed Badr; Usama El-Safy; Elisabeth Kohne; Tamer Hassan; Hadeel Abdelrahman; Mohamed Mourad; Joaquin Brintrup; Marwa Zakaria
Journal:  Biomed Rep       Date:  2016-04-04

5.  Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran.

Authors:  Alireza Abdollah Shamshirsaz; Mir Reza Bekheirnia; Mohammad Kamgar; Nima Pourzahedgilani; Navid Bouzari; Mohammadreza Habibzadeh; Reza Hashemi; Amirhooshang Abdollah Shamshirsaz; Shahriar Aghakhani; Hooman Homayoun; Bagher Larijani
Journal:  BMC Endocr Disord       Date:  2003-08-12       Impact factor: 2.763

6.  Growth and Endocrine Function in Tunisian Thalassemia Major Patients.

Authors:  Naouel Guirat Dhouib; Monia Ben Khaled; Monia Ouederni; Habib Besbes; Ridha Kouki; Fethi Mellouli; Mohamed Bejaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

7.  A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major.

Authors:  Farzad Najafipour; Akbar Aliasgarzadeh; Naser Aghamohamadzadeh; Amir Bahrami; Majid Mobasri; Mitra Niafar; Manouchehr Khoshbaten
Journal:  Ann Saudi Med       Date:  2008 Sep-Oct       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.